BPC-157 vs GHK-Cu
Both are repair-focused peptides sold together in our KLOW Blend, but they come from different research lineages entirely — one gastric-derived and systemic, the other a naturally occurring copper-binding tripeptide with an unusually solid human evidence base for a research peptide.
At a Glance
| BPC-157 | GHK-Cu | |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Molecular class | Pentadecapeptide (15 amino acids), derived from a gastric protective protein | Naturally occurring copper-binding tripeptide (3 amino acids) |
| Discovery timeline | 1975–1993, University of Zagreb | Discovered by Dr. Loren Pickart while researching aged liver tissue |
| Primary mechanism studied | Cytoprotection, angiogenesis | Copper-dependent collagen synthesis |
| Common research focus | Gastrointestinal and musculoskeletal repair research | Skin and connective-tissue research, wound healing |
| Human clinical trial data | None completed — evidence limited to animal and in-vitro research | Small-scale human data, but topical (not injectable) only |
| Sold as a blend | Yes — see KLOW Blend | Yes — see KLOW Blend |
How They Differ
BPC-157's research lineage traces to cytoprotection — the stomach's own ability to resist injury and self-digestion — and its research applications have grown outward into gastrointestinal repair, angiogenesis, and musculoskeletal healing research. See its full discovery history, or how it compares to TB-500 and KPV.
GHK-Cu is a naturally occurring peptide-copper complex, first identified during research into why aged liver tissue behaves differently from young tissue. Its research base centers specifically on copper's role as a cofactor in collagen synthesis, which is also why GHK-Cu is one of the few compounds on this site with real (though topical, not injectable) human data. See its full discovery history, or how it compares to KPV.
Why They're Often Studied Together
Because BPC-157's angiogenic/cytoprotective repair mechanism and GHK-Cu's collagen-synthesis mechanism act on different parts of the tissue-repair process, researchers studying regenerative pathways often reference both compounds — the same rationale behind combining them, alongside TB-500 and KPV, in the KLOW Blend.
BPC-157 vs GHK-Cu questions
Are BPC-157 and GHK-Cu studied the same way?
No. BPC-157's research base is gastric-derived and systemic, centered on cytoprotection and angiogenesis. GHK-Cu's research base centers on copper-dependent collagen synthesis and skin biology — a distinct line of literature, even though both appear together in the KLOW Blend.
Does either have human clinical trial data?
GHK-Cu has small-scale human data, though all of it is from topical (not injectable) application. BPC-157 has no completed human trials, with evidence limited to animal and in-vitro research.
Does this comparison mean BPC-157 and GHK-Cu are approved for a particular use?
No. This page compares BPC-157 and GHK-Cu for educational and research context only. Both are sold strictly for laboratory research use and are not evaluated or approved for human or animal use.
Looking for specs and pricing?
View purity, available sizes, and pricing for both.